Medical Device Transparency in Question: When Science Meets Spin The latest revelations about Medtronic's handling of data for its Intellis spinal cord stimulator raise serious concerns about the transparency and accountability of medical device manufacturers.
The discrepancy between the company's published studies and internal data is not just a matter of discrepancies, but also has broader implications for patient consent and regulation.
Medtronic's Intellis was approved for sale in Australia in 2018, with claims that it reduced back pain by more than half in most patients.